Lung carcinomas are represented by non-small-cell lung carcinomas (NSCLC) a
nd neuroendocrine carcinomas (NE) which differ in their clinical presentati
on and prognosis. We used comparative genomic hybridization (CGH) to charac
terize and compare the chromosomal pattern of 11 NSCLC and 11 high-grade NE
lung carcinomas. Overall, the total number of aberrations was higher in NS
CLC than in high-grade NE lung tumors (p < 0.05) and gains predominated ove
r losses in NSCLC (p < 0.0003). Gains common to both lung tumor phenotypes
were detected in 1p, 1q, 3q, 5p, 6p, 8q, 12, 17q, 19p, 19q, 20p, 20q, and X
, whereas common losses were found in 2q, 3p, 4p, 4q, 5q, 8p, 9p, 10p, 11p
11q, 13q, and 17p. Major gains on 18q and losses on 2p and 16q were exclusi
vely detected in high-grade NE lung tumors. On the other hand, major gains
on 2p and 15q and losses on 21q were found only in NSCLC. Furthermore, gain
s within 22q11 similar to q12 and 7p12 similar to p15 were associated with
NSCLC(p < 0.05). The differences in the pattern and distribution of genetic
changes observed in NSCLC as opposed to high-grade NE lung carcinomas sugg
est the existence of distinct tumorigenic pathways between these toro major
classes of lung tumors. (C) Elsevier Science Inc., 1999. All rights reserv
ed.